pI: 6.2511 |
Length (AA): 864 |
MW (Da): 93880 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
133 | 843 | 3rip (A) | 1 | 654 | 19.00 | 0 | 1 | 0.705917 | 0.93 |
501 | 843 | 3rip (A) | 324 | 654 | 22.00 | 0 | 0.99 | 0.466091 | 0.19 |
550 | 637 | 4elj (A) | 336 | 449 | 32.00 | 0.32 | 0.27 | 0.268852 | 1.02 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | amastigotes, metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_128455)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G17410 | Spc97 / Spc98 family of spindle pole body (SBP) component |
Babesia bovis | BBOV_II001290 | spc97 / spc98 family protein |
Brugia malayi | Bm1_24520 | Spc97 / Spc98 family protein |
Candida albicans | CaO19.708 | similar to S. cerevisiae SPC97 (YHR172W) spindle pole body component |
Candida albicans | CaO19.8327 | similar to S. cerevisiae SPC97 (YHR172W) spindle pole body component |
Cryptosporidium hominis | Chro.70344 | PV1H14095_P-related |
Cryptosporidium parvum | cgd7_3060 | gamma-tubulin complex associated protein |
Dictyostelium discoideum | DDB_G0285849 | spindle pole body component 97 |
Drosophila melanogaster | Dmel_CG3917 | Gamma-tubulin ring protein 84 |
Echinococcus granulosus | EgrG_000621500 | gamma tubulin complex component 2 |
Entamoeba histolytica | EHI_043950 | hypothetical protein |
Echinococcus multilocularis | EmuJ_000621500 | gamma tubulin complex component 2 |
Giardia lamblia | GL50803_17429 | Tubulin, small gamma tubulin complex gcp2 |
Homo sapiens | ENSG00000130640 | tubulin, gamma complex associated protein 2 |
Leishmania braziliensis | LbrM.35.4630 | gamma-tubulin complex subunit, putative |
Leishmania donovani | LdBPK_364610.1 | gamma-tubulin complex component 2 |
Leishmania infantum | LinJ.36.4610 | gamma-tubulin complex subunit, putative |
Leishmania major | LmjF.36.4390 | gamma-tubulin complex subunit, putative |
Leishmania mexicana | LmxM.36.4390 | gamma-tubulin complex subunit, putative |
Loa Loa (eye worm) | LOAG_06718 | hypothetical protein |
Mus musculus | ENSMUSG00000025474 | tubulin, gamma complex associated protein 2 |
Neospora caninum | NCLIV_024430 | gamma-tubulin complex component 2, putative |
Oryza sativa | 4336312 | Os04g0501700 |
Onchocerca volvulus | OVOC12221 |
|
Saccharomyces cerevisiae | YHR172W | Spc97p |
Schistosoma japonicum | Sjp_0069270 | Gamma-tubulin complex component 2, putative |
Schistosoma japonicum | Sjp_0212770 | ko:K06540 a disintegrin and metalloproteinase domain 8, putative |
Schistosoma mansoni | Smp_125530 | gamma-tubulin complex component 2 (gcp-2) |
Schmidtea mediterranea | mk4.002585.02 | Gamma-tubulin complex component 2 |
Schmidtea mediterranea | mk4.002585.03 | Gamma-tubulin complex component 2 |
Trypanosoma brucei gambiense | Tbg972.10.11940 | gamma-tubulin complex subunit, putative,spindle pole body protein, putative |
Trypanosoma brucei | Tb927.10.9770 | gamma-tubulin complex component 2 |
Trypanosoma brucei | Tb11.v5.0848 | gamma-tubulin complex subunit, putative |
Trypanosoma congolense | TcIL3000_10_8580 | gamma-tubulin complex component 2 |
Trypanosoma cruzi | TcCLB.504147.170 | gamma-tubulin complex component 2 |
Toxoplasma gondii | TGME49_263510 | Spc97 / Spc98 family protein |
Trichomonas vaginalis | TVAG_081520 | gamma tubulin complex protein, putative |
Trichomonas vaginalis | TVAG_206250 | gamma tubulin complex protein, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.9770 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.9770 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.9770 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.10.9770 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
YHR172W | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_263510 | Toxoplasma gondii | Probably essential | sidik |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.